Drawing for OLBAS

USPTO serial 79412037

OLBAS

Reviewed by CopyMark Law Group

Reg. 8007103Status 700Registered
Filing date
Status date
Registration date
Nov 4, 2025
Examiner
MANCA, ALBERTO I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OLBAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shauna L. Norton

Shauna L. Norton Dickinson Wright PLLC3883 Howard Hughes Parkway, Suite 800Las Vegas, NV 89169United States

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; cosmetic soaps; bath and shower soaps; non-medicated soaps for hands and face; non-medicated liquid soaps; perfume; bath and shower preparations, namely, shampoo, hair conditioner, skin moisturizers, bath and shower soaps, body washes, shower gels, bath foams, bath and shower creams, bath and shower mousses being foams, bath herbs, not for medical purposes, and body scrubs; bath oils; essential oils; blended essential oils; natural essential oils; body oils; massage oils; non-medicated massage oils; aromatherapy oils, namely, essential oils for use in aromatherapy; perfume oils; scented oils; aromatic oils made from herbs; tissues impregnated with essential oils; non-medicated bath preparations; bath milks; bath lotions; bath gels; bath soaks, namely, non-medicated body soaks; bubble baths; non-medicated bath salts; bathing lotions; menthol bath preparations, not for medical purposes, namely, shampoo, hair conditioner, shower gels, bath and shower soaps, body washes, bath oils, bath foams, bath and shower creams, bath and shower mousses being foams, bath herbs, not for medical purposes, and body scrubs; non-medicated balms for lips, hair, skin and bodyACTIVE—
005Medical preparations, namely, decongestants, analgesics, and medical preparations for treating and relieving symptoms of common colds, coughs, flus, hay fever, nasal and sinus congestion, nausea and sore throats, and for relief of pain, aches, and discomfort; hygienic and sanitary products for medical use, namely, medical dressings and adhesive bandages for skin wounds; medicinal tea; herbal tea for medicinal use; medicinal herb infusions for treating and relieving symptoms of common colds, coughs, flus, hay fever, nasal and sinus congestion, nausea, sore throats, and for relief of pain, aches, and discomfort; medicinal herbal supplements; extracts of medicinal herbs other than essential oils; medicinal herbal lozenges; medicated confectionery; medicinal lozenges; medicated sweets; chemical substances for medical and pharmaceutical use, namely, medicinal herbal and plant extracts and oils, clove oil, eucalyptus oil, juniper berry oil, cajuput oil, mint oil, and menthol, the foregoing not including essential oils; dietetic preparations and substances, namely, dietetic infusions for medical use, dietetic foods and beverages adapted for medical use; dietetic supplements, namely, dietary supplements, herbal supplements, health food supplements, and vitamin supplements; liniments; medicated preparations for the bath; medicated bath oils, other than essential oils; medicated tissues infused with medicinal oils; pre-moistened medicated tissues; tissues impregnated with decongestants; decongestants; oils used for medical purposes, namely, medicinal oils, other than essential oils; embrocations being liquid analgesics and medicated topical preparations for relief of pain, aches, and discomfort; medicated oils, other than essential oils; medicinal oil solutions, namely, medicinal oils, other than essential oils; medicated massage oils; nasal decongestants; decongestant nasal sprays; decongestants, namely, decongestant nasal sticks; adhesive decongestant nasal strips, namely, nasal patches impregnated with decongestants; tissues impregnated with medicinal oils, other than essential oils; tissues impregnated with pharmaceutical solutions in the nature of decongestants, analgesics, mentholated solutions, and pharmaceutical solutions for treating and relieving symptoms of common colds, coughs, flus, hay fever, nasal and sinus congestion, nausea and sore throats, and for relief of pain, aches, and discomfort; menthol bath preparations for medical purposes; multi-purpose medicated mentholated salves; adhesive transdermal patches for medicinal purposes, namely, pain relief patches, patches for relieving nasal and sinus congestion, patches for treatment of common colds, and patches impregnated with pharmaceutical solutions for treating and relieving symptoms of common colds, coughs, flus, hay fever, nasal and sinus congestion, nausea and sore throats, and for relief of pain, aches, and discomfort; adhesive patches for decongestant purposes, namely, transdermal patches impregnated with decongestants, diffusion patches impregnated with decongestants, and patches for airborne diffusion of decongestants; adhesive patches impregnated with medicinal oils, other than essential oils; Transdermal patches for medicinal purposes impregnated with decongestants and analgesics, and medical preparations for pain relief, and for treatment of common colds, coughs, flus, hay fever, sore throats, nasal and sinus congestion, and nausea; transdermal patches for decongestant purposes, namely, transdermal patches impregnated with decongestants; medicated soapsACTIVE—
010Inhalers, for medical purposes, sold empty; nasal inhalers, for medical purposes, sold empty; vaporisers for medical purposes, being vaporisers for oils and medicinal substancesACTIVE—
030Confectionery, namely, candies and sweets; lozenges being non-medicated confectionery; pastilles being non-medicated confectionery; non-medicated throat pastilles; hard candies; candy coated confections, namely, non-medicated candy-coated lozenges, candy-coated pastilles; non-medicated candy; non-medicated sweets; sugar-free sweetsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 28, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 15, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB—
May 15, 2026XXCRGENERIC MADRID TRANSACTION CREATED—
May 11, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 11, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 23, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 4, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Aug 14, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 14, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 14, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 29, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 27, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 27, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 27, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 2, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 15, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 27, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 27, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2025DOCKASSIGNED TO EXAMINER—
Dec 13, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance